NAT5 Polyclonal antibody

NAT5 Polyclonal Antibody for WB, IP, IF, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IP, IF, ELISA

Conjugate

Unconjugated

Cat no : 15807-1-AP

Synonyms

N acetyltransferase 5, NAA20, NAT3, NAT5, NatB complex subunit NAT5



Tested Applications

Positive WB detected inHeLa cells, HL-60 cells, human brain tissue
Positive IP detected inHL-60 cells
Positive IF detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunofluorescence (IF)IF : 1:50-1:500
Sample-dependent, check data in validation data gallery

Published Applications

WBSee 2 publications below

Product Information

15807-1-AP targets NAT5 in WB, IP, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivity human, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen NAT5 fusion protein Ag8541 相同性解析による交差性が予測される生物種
Full Name N-acetyltransferase 5 (GCN5-related, putative)
Calculated molecular weight 178 aa, 20 kDa
Observed molecular weight 18-20 kDa
GenBank accession numberBC005181
Gene symbol NAT5
Gene ID (NCBI) 51126
RRIDAB_1640056
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
WB protocol for NAT5 antibody 15807-1-APDownload protocol
IF protocol for NAT5 antibody 15807-1-APDownload protocol
IP protocol for NAT5 antibody 15807-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
mouseWB

Int J Mol Sci

NatB Catalytic Subunit Depletion Disrupts DNA Replication Initiation Leading to Senescence in MEFs

Authors - Jasmin Elurbide
humanWB

Oncotarget

NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma.

Authors - Leire Neri